SP
Synovics Pharmaceuticals Stock: price and insider trades · United States
Synovics Pharmaceuticals: what insiders have been doing
Insider filings for Synovics Pharmaceuticals are scarce in the SEC (Form 4) feed, the latest one published on 3 October 2006. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
6
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€172,557
1 ops. · all time
Financial data
· cache
US$0.00
Analyst consensus
Income statement
EBITDA-US$3.6M
Valuation
Beta74.62
Profitability & ownership
ROE-314.3%
ROA-12.7%
Last declaration on 3 October 2006
Declarations6 total
- 550,000 shares@ US$0.38Common Stock, par value $0.001SEC:0001144204-06-040673:0
- 50,000 shares@ US$0.50Common Stock, par value $0.001SEC:0001144204-06-040673:1
- 10,000 shares@ US$0.50Common Stock, par value $0.001SEC:0001144204-06-040673:2
- 5,000 shares@ US$0.50Common Stock, par value $0.001SEC:0001144204-06-040673:5
- 4,000 shares@ US$0.50Common Stock, par value $0.001SEC:0001144204-06-040673:6
- 1,000,000 shares@ US$3.00Common StockSEC:0001144204-06-015256:0
6 of 6 declarations
About Synovics Pharmaceuticals
Synovics Pharmaceuticals is a company focused on the development of innovative pharmaceuticals. It is listed on the XNAS market.
